Which hedge funds own CNTB? CONNECT BIOPHARMA HLDGS LTD, Q2 2026 13F holders
3 of the hedge funds tracked by WhaleCreep disclosed a position in CNTB (CONNECT BIOPHARMA HLDGS LTD) in their Q2 2026 13F filings, worth $1.1m in total. The largest holder by portfolio weight is Marshall Wace at 0.0% of its book. 2 exited: Citadel Advisors, Point72 Asset Management LP.
3tracked managers holding
0opened this quarter
2exited this quarter
Which hedge funds hold CNTB? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Marshall Wace | Q2 2026 | 0.0% | $798.8k | 335,642 | 408% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $207.8k | 87,300 | -28% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $104.0k | 43,708 | -91% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Citadel Advisors | 0.0% | $199.3k |
| Point72 Asset Management LP | 0.0% | $51.8k |
How has hedge fund ownership of CNTB changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 3 | $1.1m |
| Q1 2026 | 5 | $2.0m |
| Q4 2025 | 2 | $450.1k |
| Q3 2025 | 1 | $238.9k |
| Q2 2025 | 1 | $140.8k |
| Q1 2025 | 1 | $63.1k |
| Q4 2024 | 1 | $185.9k |
| Q3 2024 | 1 | $252.7k |
| Q2 2024 | 1 | $322.7k |
| Q1 2024 | 1 | $417.0k |
| Q4 2023 | 2 | $4.0m |
| Q3 2023 | 2 | $5.8m |
| Q2 2023 | 2 | $8.0m |
| Q1 2023 | 2 | $7.1m |
| Q4 2022 | 2 | $6.1m |
| Q3 2022 | 2 | $9.1m |
Counts every tracked manager that disclosed CNTB in that quarter's filing, including managers that have since stopped filing.